Covered recipient · General Payments record
DEBBIE LIM
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,620.58
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $709.65 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $388.72 | 18 |
| Amgen Inc. | $139.70 | 10 |
| Lilly USA, LLC | $48.74 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.20 | 2 |
| Acerta Pharma LLC | $24.56 | 1 |
| Octapharma USA, Inc. | $24.34 | 1 |
| Sandoz Inc. | $24.09 | 1 |
| Genentech USA, Inc. | $22.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.39 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882701 | CMS |
| ABBVIE INC. | $109.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882703 | CMS |
| ABBVIE INC. | $18.96 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882705 | CMS |
| ABBVIE INC. | $18.37 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882707 | CMS |
| ABBVIE INC. | $7.85 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882709 | CMS |
| ABBVIE INC. | $14.82 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882711 | CMS |
| ABBVIE INC. | $15.51 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882713 | CMS |
| ABBVIE INC. | $26.34 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882715 | CMS |
| ABBVIE INC. | $9.42 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882717 | CMS |
| ABBVIE INC. | $5.79 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882719 | CMS |
| ABBVIE INC. | $13.98 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882721 | CMS |
| ABBVIE INC. | $13.14 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882723 | CMS |
| ABBVIE INC. | $7.58 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882725 | CMS |
| ABBVIE INC. | $27.35 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882727 | CMS |
| ABBVIE INC. | $18.52 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882729 | CMS |
| ABBVIE INC. | $19.50 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882731 | CMS |
| ABBVIE INC. | $15.85 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882733 | CMS |
| ABBVIE INC. | $27.44 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104882735 | CMS |
| Amgen Inc. | $12.73 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634986 | CMS |
| Amgen Inc. | $12.30 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634988 | CMS |
| Amgen Inc. | $9.50 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634976 | CMS |
| Amgen Inc. | $5.54 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117310949 | CMS |
| Amgen Inc. | $21.86 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634990 | CMS |
| Amgen Inc. | $9.29 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634978 | CMS |
| Amgen Inc. | $7.33 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634980 | CMS |
| Amgen Inc. | $7.26 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634982 | CMS |
| Amgen Inc. | $44.59 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634974 | CMS |
| Amgen Inc. | $9.30 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111634984 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.56 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104545542 | CMS |
| Genentech USA, Inc. | $22.30 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133000062 | CMS |
| Lilly USA, LLC | $14.93 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136136528 | CMS |
| Lilly USA, LLC | $16.03 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136138813 | CMS |
| Lilly USA, LLC | $17.78 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136136526 | CMS |
| Novartis Pharmaceuticals Corporation | $18.74 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087105930 | CMS |
| Novartis Pharmaceuticals Corporation | $18.46 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087105938 | CMS |
| Octapharma USA, Inc. | $24.34 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142316529 | CMS |
| Sandoz Inc. | $24.09 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.